{
    "2018-09-05": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Could 2018's Best-Performing Big Pharma Stock So Far Go Even Higher Soon?",
                "features": {
                    "keywords": [
                        "Best-Performing",
                        "Big Pharma",
                        "Higher",
                        "Soon"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-03",
                "original_text": "J&J Submits NDA to the FDA for Depression Drug in Adults",
                "features": {
                    "keywords": [
                        "J&J",
                        "NDA",
                        "FDA",
                        "Depression Drug"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "Lilly Announces Positive Phase 3 Results in Study of Flortaucipir PET Imaging Agent",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Positive Phase 3",
                        "Flortaucipir",
                        "PET Imaging"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "Eli Lilly Has Trimmed Its Stake in Biopharma Firm Zymeworks",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Trimmed Stake",
                        "Zymeworks"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-06",
                "original_text": "Endo (ENDP) Hits 52-Week High, Can the Run Continue?",
                "features": {
                    "keywords": [
                        "Endo",
                        "52-Week High",
                        "Run Continue"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-07",
                "original_text": "Invesco Dynamic Pharmaceuticals ETF Experiences Big Inflow",
                "features": {
                    "keywords": [
                        "Invesco",
                        "Pharmaceuticals ETF",
                        "Big Inflow"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-08",
                "original_text": "3 Big Stock Charts for Wednesday: FMC, Eli Lilly and Hewlett Packard Enterprise",
                "features": {
                    "keywords": [
                        "Stock Charts",
                        "FMC",
                        "Eli Lilly",
                        "Hewlett Packard Enterprise"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals",
                        "technology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-09",
                "original_text": "Boost for 'made in China' medicine as Chi-Med wins key approval",
                "features": {
                    "keywords": [
                        "made in China",
                        "Chi-Med",
                        "key approval"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-10",
                "original_text": "BCRX At Its Zenith, CRON Walks The Walk, TSRO To Report Data In Nov.",
                "features": {
                    "keywords": [
                        "BCRX",
                        "CRON",
                        "TSRO",
                        "Report Data"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}